Legend Biotech Statistics
NASDAQ: LEGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.45-0.6701 (-3.50%)
Market open · Delayed 15 min · as of Oct 8, 2:25 PM ET
Legend Biotech by the numbers
Legend Biotech has a market capitalization of $3.59 billion based on 194.49M shares outstanding. With trailing EPS of $-0.52, Legend Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.7% below its 50-day average and 17.5% below its 200-day average.
Average daily trading volume is 2.36M shares, or about $43.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LEGN valuation vs. peer median
| Metric | LEGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.59B | $3.58B | +0% |
| Avg. volume | 2.36M | 2.02M | +17% |
Peer median across 8 companies: TNGX, TLX, OGN, PBLS, ABCL, VKTX, XENE, IDYA.
Valuation
- Market cap
- $3.59B
- Forward P/E
- 17.57
- Price / sales (latest FY)
- 3.49
- EPS (TTM)
- $-0.52
- Shares outstanding
- 194.49M
Price and trading
- Previous close
- 19.12
- Open
- 18.91
- Day range
- 18.09 – 18.91
- 52-week range
- 16.24 – 37.50
- 52-week change
- -39.13%
- Beta
- —
- Volume
- 1.38M
- Average volume
- 2.36M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 3.59B
- Forward Pe
- 17.57
- Eps
- -0.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.50
- Week52 Low
- 16.24
- Avg Volume
- 2.36M
- Shares Outstanding
- 194.49M
- Ma50
- 19.77
- Ma200
- 22.37
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -50.80%
- Pct From52w Low
- 13.61%